PHARMACOKINETIC CONSIDERATIONS ON RESISTANCE TO ANTICANCER DRUGS

被引：0
|
作者：
DEDRICK, RL
ZAHARKO, DS
BENDER, RA
BLEYER, WA
LUTZ, RJ
机构：
[1] NIH, DIV RES SERV,BIOMED ENGN & INSTRUMENTATION BRANCH, BLDG 13,ROOM 3W13, BETHESDA, MD 20014 USA
[2] NCI, DIV CANC TREATMENT, PHARMACOKINETICS & PHARMACODYN SECT, LAB CHEM PHARMACOL, BETHESDA, MD USA
[3] UNIV WASHINGTON, CHILDRENS ORTHOPEDIC HOSP, DEPT PEDIAT, DIV HEMATOL ONCOL, SEATTLE, WA USA
[4] NCI, DIV CANC TREATMENT, MED BRANCH, BETHESDA, MD USA
来源：
CANCER CHEMOTHERAPY REPORTS PART 1 | 1975年 / 59卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：795 / 804
页数：10
相关论文
共 50 条
  • [31] POISONING BY TRICYCLIC ANTIDEPRESSANT DRUGS - GENERAL AND PHARMACOKINETIC CONSIDERATIONS
    BICKEL, MH
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND BIOPHARMACY, 1975, 11 (02): : 145 - 176
  • [32] Pharmacokinetic considerations for anti-epileptic drugs in children
    Verrotti, Alberto
    Iapadre, Giulia
    Di Donato, Giulia
    Di Francesco, Ludovica
    Zagaroli, Luca
    Matricardi, Sara
    Belcastro, Vincenzo
    Iezzi, Maria Laura
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (03) : 199 - 211
  • [33] ANTIMICROBIAL RESISTANCE AND EXTRAGENITAL STIS - PHARMACOKINETIC CONSIDERATIONS
    Kong, F.
    SEXUALLY TRANSMITTED INFECTIONS, 2021, 97 : A6 - A7
  • [34] Herbal Interactions with Anticancer Drugs: Mechanistic and Clinical Considerations
    Yang, An-Kui
    He, Shu-Ming
    Liu, Liang
    Liu, Jun-Ping
    Wei, Ming Qian
    Zhou, Shu-Feng
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (16) : 1635 - 1678
  • [35] Oral delivery of anticancer drugs I: general considerations
    Mazzaferro, Silvia
    Bouchemal, Kawthar
    Ponchel, Gilles
    DRUG DISCOVERY TODAY, 2013, 18 (1-2) : 25 - 34
  • [36] Role of pharmacokinetic modeling and simulation in precision dosing of anticancer drugs
    Darwich, Adam S.
    Ogungbenro, Kayode
    Hatley, Oliver J.
    Rostami-Hodjegan, Amin
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S1512 - +
  • [37] PHARMACOKINETIC DRUG-INTERACTIONS OF COMMONLY USED ANTICANCER DRUGS
    BALIS, FM
    CLINICAL PHARMACOKINETICS, 1986, 11 (03) : 223 - 235
  • [38] PHARMACOKINETIC STUDIES OF ANTICANCER DRUGS IN TUMOR-BEARING ANIMALS
    DONELLI, MG
    DINCALCI, M
    GARATTINI, S
    CANCER TREATMENT REPORTS, 1984, 68 (02): : 381 - 400
  • [39] Pharmacokinetic interactions of selected anticancer drugs with doxorubicin reducing enzymes
    Hofman, J.
    Skarka, A.
    Havrankova, J.
    Maser, E.
    Wsol, V
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 : S47 - S47
  • [40] OVEREXPRESSION OF METALLOTHIONEIN CONFERS RESISTANCE TO ANTICANCER DRUGS
    KELLEY, SL
    BASU, A
    TEICHER, BA
    HACKER, MP
    HAMER, DH
    LAZO, JS
    SCIENCE, 1988, 241 (4874) : 1813 - 1815
12345